Predictions for the Generic Drug Sector in 2018
PCI Synthesis shares expected trends in the industry within the next year
Posted: January 9, 2018
Contract Pharma published PCI Synthesis’s Predictions for the Generic Drug Sector in 2018. Here are some of the trends that PCI Synthesis shared, which they expect will impact the industry next year
Read the Full Article and watch the video »
Related posts:
How to grow biotech R&D jobs in Massachusetts
Six Tips for Leveraging Values, Ethics and Compliance in Successful Drug Development
Why a CDMO more efficient tham CRO+CMO
The Long Paper Trail of Documentation in API Manufacturing
The trend now is for pharmaceutical companies to forego the expensive, time consuming and risky tran...
About the Author
Ed is the President and CEO of PCI Synthesis (PCI), he serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA).